Makiko Abe1,2, Hidemi Ito3,4, Isao Oze3, Masatoshi Nomura2, Yoshihiro Ogawa2,5, Keitaro Matsuo6,7. 1. Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, 812-8582, Japan. 2. Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu University, Fukuoka, 812-8582, Japan. 3. Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan. 4. Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, 466-8560, Japan. 5. Department of Molecular and Cellular Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan. 6. Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan. kmatsuo@aichi-cc.jp. 7. Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, 466-8560, Japan. kmatsuo@aichi-cc.jp.
Abstract
BACKGROUND: Little is known about the difference of genetic predisposition for CRC between ethnicities; however, many genetic traits common to colorectal cancer have been identified. This study investigated whether more SNPs identified in GWAS in East Asian population could improve the risk prediction of Japanese and explored possible application of genetic risk groups as an instrument of the risk communication. METHODS: 558 Patients histologically verified colorectal cancer and 1116 first-visit outpatients were included for derivation study, and 547 cases and 547 controls were for replication study. Among each population, we evaluated prediction models for the risk of CRC that combined the genetic risk group based on SNPs from GWASs in European-population and a similarly developed model adding SNPs from GWASs in East Asian-population. We examined whether adding East Asian-specific SNPs would improve the discrimination. RESULTS: Six SNPs (rs6983267, rs4779584, rs4444235, rs9929218, rs10936599, rs16969681) from 23 SNPs by European-based GWAS and five SNPs (rs704017, rs11196172, rs10774214, rs647161, rs2423279) among ten SNPs by Asian-based GWAS were selected in CRC risk prediction model. Compared with a 6-SNP-based model, an 11-SNP model including Asian GWAS-SNPs showed improved discrimination capacity in Receiver operator characteristic analysis. A model with 11 SNPs resulted in statistically significant improvement in both derivation (P = 0.0039) and replication studies (P = 0.0018) compared with six SNP model. We estimated cumulative risk of CRC by using genetic risk group based on 11 SNPs and found that the cumulative risk at age 80 is approximately 13% in the high-risk group while 6% in the low-risk group. CONCLUSION: We constructed a more efficient CRC risk prediction model with 11 SNPs including newly identified East Asian-based GWAS SNPs (rs704017, rs11196172, rs10774214, rs647161, rs2423279). Risk grouping based on 11 SNPs depicted lifetime difference of CRC risk. This might be useful for effective individualized prevention for East Asian.
BACKGROUND: Little is known about the difference of genetic predisposition for CRC between ethnicities; however, many genetic traits common to colorectal cancer have been identified. This study investigated whether more SNPs identified in GWAS in East Asian population could improve the risk prediction of Japanese and explored possible application of genetic risk groups as an instrument of the risk communication. METHODS: 558 Patients histologically verified colorectal cancer and 1116 first-visit outpatients were included for derivation study, and 547 cases and 547 controls were for replication study. Among each population, we evaluated prediction models for the risk of CRC that combined the genetic risk group based on SNPs from GWASs in European-population and a similarly developed model adding SNPs from GWASs in East Asian-population. We examined whether adding East Asian-specific SNPs would improve the discrimination. RESULTS: Six SNPs (rs6983267, rs4779584, rs4444235, rs9929218, rs10936599, rs16969681) from 23 SNPs by European-based GWAS and five SNPs (rs704017, rs11196172, rs10774214, rs647161, rs2423279) among ten SNPs by Asian-based GWAS were selected in CRC risk prediction model. Compared with a 6-SNP-based model, an 11-SNP model including Asian GWAS-SNPs showed improved discrimination capacity in Receiver operator characteristic analysis. A model with 11 SNPs resulted in statistically significant improvement in both derivation (P = 0.0039) and replication studies (P = 0.0018) compared with six SNP model. We estimated cumulative risk of CRC by using genetic risk group based on 11 SNPs and found that the cumulative risk at age 80 is approximately 13% in the high-risk group while 6% in the low-risk group. CONCLUSION: We constructed a more efficient CRC risk prediction model with 11 SNPs including newly identified East Asian-based GWAS SNPs (rs704017, rs11196172, rs10774214, rs647161, rs2423279). Risk grouping based on 11 SNPs depicted lifetime difference of CRC risk. This might be useful for effective individualized prevention for East Asian.
Entities:
Keywords:
Colorectal cancer risk; Cumulative incidence; GWAS; Risk prediction model
Authors: Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston Journal: Nat Genet Date: 2008-04-02 Impact factor: 38.330
Authors: Maurice Chan; Mei Wen Chan; Ting Wei Loh; Hai Yang Law; Chui Sheun Yoon; Sint Sint Than; Jia Mei Chua; Chow Yin Wong; Wei Sean Yong; Yoon Sim Yap; Gay Hui Ho; Peter Ang; Ann Siew Gek Lee Journal: J Mol Diagn Date: 2011-05 Impact factor: 5.568
Authors: David Cunningham; Wendy Atkin; Heinz-Josef Lenz; Henry T Lynch; Bruce Minsky; Bernard Nordlinger; Naureen Starling Journal: Lancet Date: 2010-03-20 Impact factor: 79.321
Authors: R Cui; Y Okada; S G Jang; J L Ku; J G Park; Y Kamatani; N Hosono; T Tsunoda; V Kumar; C Tanikawa; N Kamatani; R Yamada; M Kubo; Y Nakamura; K Matsuda Journal: Gut Date: 2011-01-17 Impact factor: 23.059
Authors: Ian P M Tomlinson; Luis G Carvajal-Carmona; Sara E Dobbins; Albert Tenesa; Angela M Jones; Kimberley Howarth; Claire Palles; Peter Broderick; Emma E M Jaeger; Susan Farrington; Annabelle Lewis; James G D Prendergast; Alan M Pittman; Evropi Theodoratou; Bianca Olver; Marion Walker; Steven Penegar; Ella Barclay; Nicola Whiffin; Lynn Martin; Stephane Ballereau; Amy Lloyd; Maggie Gorman; Steven Lubbe; Bryan Howie; Jonathan Marchini; Clara Ruiz-Ponte; Ceres Fernandez-Rozadilla; Antoni Castells; Angel Carracedo; Sergi Castellvi-Bel; David Duggan; David Conti; Jean-Baptiste Cazier; Harry Campbell; Oliver Sieber; Lara Lipton; Peter Gibbs; Nicholas G Martin; Grant W Montgomery; Joanne Young; Paul N Baird; Steven Gallinger; Polly Newcomb; John Hopper; Mark A Jenkins; Lauri A Aaltonen; David J Kerr; Jeremy Cheadle; Paul Pharoah; Graham Casey; Richard S Houlston; Malcolm G Dunlop Journal: PLoS Genet Date: 2011-06-02 Impact factor: 5.917
Authors: Luis M Real; Agustín Ruiz; Javier Gayán; Antonio González-Pérez; María E Sáez; Reposo Ramírez-Lorca; Francisco J Morón; Juan Velasco; Ruth Marginet-Flinch; Eva Musulén; José M Carrasco; Concha Moreno-Rey; Enrique Vázquez; Manuel Chaves-Conde; Jose A Moreno-Nogueira; Manuel Hidalgo-Pascual; Eduardo Ferrero-Herrero; Sergi Castellví-Bel; Antoni Castells; Ceres Fernandez-Rozadilla; Clara Ruiz-Ponte; Angel Carracedo; Beatriz González; Sergio Alonso; Manuel Perucho Journal: PLoS One Date: 2014-06-30 Impact factor: 3.240
Authors: Catherine L Saunders; Britt Kilian; Deborah J Thompson; Luke J McGeoch; Simon J Griffin; Antonis C Antoniou; Jon D Emery; Fiona M Walter; Joe Dennis; Xin Yang; Juliet A Usher-Smith Journal: Cancer Prev Res (Phila) Date: 2020-02-18
Authors: Iker Alegria-Lertxundi; Carmelo Aguirre; Luis Bujanda; Francisco Javier Fernández; Francisco Polo; José M Ordovás; M Carmen Etxezarraga; Iñaki Zabalza; Mikel Larzabal; Isabel Portillo; Marian M de Pancorbo; Leire Palencia-Madrid; Ana M Rocandio; Marta Arroyo-Izaga Journal: PLoS One Date: 2019-12-10 Impact factor: 3.240